Observatoire des droits humains (anglais seulement)

Wegovy and Ozempic: could the new weight-loss drug also treat dementia?

(Version anglaise seulement)

par Tim Viney, Career Development Fellow, University of Oxford
Barbara Sarkany, DPhil Candidate, Alzheimer's, University of Oxford

Over 55 million people worldwide have dementia. This mind-robbing disease has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new weight-loss jab, Wegovy.

Although age is by far the greatest risk factor for dementia, obesity and type 2 diabetes are also major risk factors for developing…

Lire l'article complet